Costa, Sarah http://orcid.org/0000-0001-8166-4797
Regier, Dean A.
Raymakers, Adam J. N.
Pollard, Samantha
Funding for this research was provided by:
Genome Canada (271LYM)
Genome British Columbia (271LYM)
Canadian Institutes of Health Research (GP1-155873)
Canadian Centre for Applied Research in Cancer Control (2015-703549)
BC Cancer Foundation
Article History
First Online: 1 September 2020
Declarations
:
: This research was supported by Genome BC/Genome Canada (271LYM), CIHR (GP1-155873), the Canadian Centre for Applied Research in Cancer Control (ARCC), and the BC Cancer Foundation. ARCC is funded by the Canadian Cancer Society (2015-703549).
: Adam JN Raymakers (AJNR) has received compensation from CADTH, specifically from the pan-Canadian Oncology Drug Review (pCODR), for providing economic guidance about oncology drug submissions.
: The datasets generated and/or analyzed during the current study are not publicly available to protect the confidentiality of participants. De-identified data may be available from the corresponding author on reasonable request.
: This study received ethics approval from the University of British Columbia – BC Cancer Research Ethics Board (H18-00490).
: All participants were required to sign a consent form prior to participation in the study.
: SC, DAR, AJNR, and SP contributed to the design of the research study. SC and SP conducted all participant recruitment and led the focus group sessions, supported by AJNR who took notes. SP and SC conducted the qualitative analysis. All authors were involved in the interpretation of the results and manuscript development. All authors read, reviewed, and approved the final manuscript.